CAMBRIDGE, Mass., Dec. 8 /PRNewswire-FirstCall/ -- Infinity Pharmaceuticals, Inc. today announced that Jeffrey K. Tong, Vice President, Corporate and Product Development, will participate in a panel discussion at the RBC Capital Markets Healthcare Conference at The Westin New York at Times Square in New York City. The "New Therapies in Oncology" panel discussion will begin at 2:30 p.m. EST on Wednesday, December 13, 2006.
A live webcast of the panel discussion will be available in the "Events and Presentations" section of the Investor page of Infinity's website at http://www.ipi.com. An archive of the discussion will be accessible for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com.
Contacts: Investors: John Evans 617.453.1254 John.Evans@ipi.com Media : Monique Allaire 617.453.1105 Monique.Allaire@ipi.com
Infinity Pharmaceuticals, Inc.CONTACT: Investors: John Evans, +1-617-453-1254, John.Evans@ipi.com, orMedia: Monique Allaire, +1-617-453-1105, Monique.Allaire@ipi.com, both ofInfinity Pharmaceuticals, Inc.
Web site: http://www.ipi.com//
